Mark Martin says NASCAR committee talks included a full-season pointsas officials review possible playoff format changes for 2026.

If you ask any long-time fan to name the best driver to never win a Cup Series championship, one name usually rises above the rest: Martin. But defining Mark Martin by what he didn’t win does a ...

NASCAR icon Mark Martin joins Paul Tracy on Racers Unchained for a wide-ranging, brutally honest conversation about racing, confidence, aging, and the evolution of the sport.

Mark Martin reveals how he fought with NASCAR executives over the playoff format, stating that fans everywhere dislike the ...

Mark Martin is among the many who has felt the loss of Greg Biffle deeply. The two were teammates at Roush Racing for four ...

Mark Martin built a career that shatters the lazy idea that greatness is measured only in trophies. His record, his ...

Dean Martin destroyed his expensive Stutz vintage car in a McDonald's drive-thru to get a burger for Bing Crosby's grandson ...

The therapy YP05002 is part of the GLP-1 agonist class of drugs and is currently in early-stage development. Sign up here. Under the terms of the agreement, YaoPharma will complete the ongoing ...

With COVID sales falling and patent protections expiring, Pfizer is forecasting its 2026 revenue to be in the range of $59.5 billion to $62.5 billion. The midpoint of the projection ($61 billion) ...

The antitrust trial between NASCAR and two of its Cup teams has entered its fifth day, and the tension keeps rising as more witnesses take the stand. Michael Jordan, co-owner of 23XI Racing, is ...

Pfizer’s stock rebounded from April lows yet still trades as if COVID and patent cliffs equal business ruin, despite resilient non‑COVID franchises and pipeline optionality. Q3 looked weak, with ...

Pfizer’s VC arm has backed a $100 million series A raise for OTR Therapeutics as the Chinese biotech tacks on preclinical neurological assets to its varied portfolio. Shanghai-based OTR raised the ...